MESENCHYMAL STROMAL CELL THERAPY ALONE DOES NOT LEAD TO COMPLETE RESTORATION OF SKIN PARAMETERS IN DIABETIC FOOT PATIENTS WITHIN A 3-YEAR FOLLOW-UP PERIOD ArticleMaksimova N.V., Michenko A.V., Krasilnikova O.A., Klabukov I.D., Gadaev I.Yu., Krasheninnikov M.E., Belkov P.A., Lyundup A.V.BioImpacts. Том 12. 2022. С. 51-55
ASSESSMENT OF IMMUNOLOGICAL RESPONSES - A NOVEL CHALLENGE IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE ArticleShestakova Victoria A., Klabukov Ilya D., Baranovskii Denis S., Shegay Petr V., Kaprin Andrey D.Biomedical Research and Therapy. Том 9. 2022. С. 5384-5386
STEM AND SOMATIC CELL MONOTHERAPY FOR THE TREATMENT OF DIABETIC FOOT ULCERS: REVIEW OF CLINICAL STUDIES AND MECHANISMS OF ACTION ArticleKrasilnikova O.A., Baranovskii D.S., Lyundup A.V., Shegay P.V., Kaprin A.D., Klabukov I.D.Stem Cell Reviews and Reports. 2022.
ADVERSE EVENTS, SIDE EFFECTS AND COMPLICATIONS IN MESENCHYMAL STROMAL CELL-BASED THERAPIES ArticleBaranovskii Denis S., Klabukov Ilya D., Arguchinskaya Nadezhda V., Yakimova Anna O., Kisel Anastas A., Yatsenko Elena M., Ivanov Sergei A., Shegay Peter V., Kaprin Andrey D.Stem Cell Investigation. Том 9. 2022. С. 7-7
